The US Food and Drug Administration (FDA) has cleared Vent Creativity’s Hermes Knee, an AI-driven software solution for knee arthroplasty procedures.

The solution uses deep learning to create surgical plans for various alignment techniques, including kinematic, anatomical, and mechanical, intended for total and partial arthroplasty procedures.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Built on the Minerva platform, the company noted that Hermes Knee can also plan and analyse research applications for other indications.

The software provides users with a bone structure interaction, using intensity representations in a patented “point cloud” format. This enables radiologists and surgeons to evaluate human phenotypes and arthritic state variations.

The resulting cut planes, screw trajectories and other operations can be visualised before surgery, allowing for evaluation and comparison of the patient’s case with prior cases.

According to Vent Creativity, the “cloud-based“system works via secured protocols, enabling surgeons to modify resulting plans that can be annotated to highlight areas of concern and generate reports for documentation purposes.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Such reports may be used for outcome studies, potential reimbursement, and other professional uses.

The software is currently available in the US for clinical usage, initially focusing on computed tomography (CT)-based knee arthroplasty surgical planning.

Vent Creativity CEO Gilly Yildirim said: “We are a company of industry professionals who have worked on every aspect of the orthopaedic and medical technology and have identified patient-specific planning with digital-twin informed technologies to be the missing link in the reported outcomes.

“Our unique approach to everything in healthcare is our strength as we have shown a free and fast-moving path to patents, publications, and regulatory submissions.”

AI-driven digital-twinning company Vent focuses on generating surgical planning software that offers workflows for patient-specific solutions.

Its patented point,cloud and wave-based tracking solutions provide insights for medical professionals in both corporate settings and operating rooms.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact